Rensselaer researchers receive $6.4 million grant from NEI to seek new treatment for blindness-causing diseases.

“These are devastating diseases with limited treatment options,” said Curt Breneman, Ph.D., dean of Rensselaer’s School of ...

Rensselaer Polytechnic Institute's Christopher Cioffi, Ph.D., Thomas and Constance D'Ambra Professor in Organic Chemistry, has been collaborating with Konstantin Petrukhin, Ph.D., Professor of ...

Tinlarebant works by reducing and maintaining levels of serum retinol binding protein 4 (RBP4), the sole carrier protein for retinol transport from the liver to the eye. By modulating the amount ...

This research endeavors to elucidate the causal dynamics among plasma metabolites, proteins, and PCOS ... the interplay between KRT19 and potential drug candidates (Figure 4). The results highlighted ...

Tinlarebant works by reducing and maintaining levels of serum retinol binding protein 4 (RBP4), the sole carrier protein for retinol transport from the liver to the eye. By modulating the amount of ...